SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001140361-23-049220
Filing Date
2023-10-23
Accepted
2023-10-23 21:32:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6871
  Complete submission text file 0001140361-23-049220.txt   8251
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-40782 | Film No.: 231341021
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UROVANT SCIENCES, INC. 5151 CALIFORNIA AVENUE, SUITE 250 IRVINE CA 92617
Business Address
Gline Matthew (Reporting) CIK: 0001750094 (see all company filings)

Type: 144